Kestra Medical Technologies, Ltd. (KMTS)

NASDAQ: KMTS · Real-Time Price · USD

Compare

24.00

-0.39 (-1.60%)

At close: Oct 8, 2025, 4:00 PM EDT

24.00

0.00 (0.00%)

After-hours: Oct 8, 2025, 4:00 PM EDT

KMTS Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020
Revenue	66.4	59.82	27.81	7.63	-	-
Revenue Growth (YoY)	85.20%	115.05%	264.54%	-	-	-
Cost of Revenue	37.54	35.61	27.45	18.28	-	-
Gross Profit	28.86	24.21	0.36	-10.65	-	-
Selling, General & Admin	129.44	114.94	69.94	54.01	13.9	6.52
Research & Development	16.25	15.65	15.49	15.76	18.81	22.8
Operating Expenses	145.69	130.59	85.43	69.77	32.71	29.32
Operating Income	-116.83	-106.38	-85.06	-80.42	-32.71	-29.32
Interest Expense	-7.77	-7.73	-6.23	-5.63	-1.17	-
Interest & Investment Income	5.33	3.2	-	-	-	-
Other Non Operating Income (Expenses)	0.11	-2.77	-0.09	1.83	-0.04	-
EBT Excluding Unusual Items	-119.16	-113.68	-91.38	-84.22	-33.91	-29.32
Other Unusual Items	-	-	-2.72	-	-	-
Pretax Income	-119.16	-113.68	-94.1	-84.22	-33.91	-29.32
Income Tax Expense	0.16	0.14	0.02	0.02	0.19	0.15
Net Income	-119.76	-113.81	-94.12	-84.24	-34.1	-29.47
Preferred Dividends & Other Adjustments	9.94	12.32	6.72	2.5	-	-
Net Income to Common	-129.69	-126.14	-100.84	-86.74	-34.1	-29.47
Shares Outstanding (Basic)	32	25	20	0	0	0
Shares Outstanding (Diluted)	32	25	20	0	0	0
Shares Change (YoY)	30.64%	23.63%	18693.84%	-	-	-
EPS (Basic)	-4.00	-5.13	-5.07	-819.76	-322.29	-278.50
EPS (Diluted)	-4.00	-5.13	-5.07	-819.76	-322.29	-278.50
Free Cash Flow	-111.19	-101.2	-84.75	-85.1	-30.23	-30.53
Free Cash Flow Per Share	-3.43	-4.12	-4.26	-804.32	-285.72	-288.49
Gross Margin	43.46%	40.48%	1.30%	-139.59%	-	-
Operating Margin	-175.93%	-177.84%	-305.83%	-1054.01%	-	-
Profit Margin	-195.31%	-210.88%	-362.56%	-1136.79%	-	-
Free Cash Flow Margin	-167.44%	-169.19%	-304.70%	-1115.37%	-	-
EBITDA	-109.2	-98.41	-73.5	-75.57	-32.29	-28.84
EBITDA Margin	-164.45%	-164.52%	-264.27%	-	-	-
D&A For EBITDA	7.62	7.97	11.56	4.86	0.42	0.48
EBIT	-116.83	-106.38	-85.06	-80.42	-32.71	-29.32
EBIT Margin	-175.93%	-177.84%	-	-	-	-

Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q